Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

Dow Jones
03-31
 

By Dean Seal

 

Shares of vaccine companies dropped after the Food and Drug Administration's top vaccine official was pushed out in a clash with Health and Human Services Secretary Robert F. Kennedy Jr.

Moderna's stock fell 13% to $27.18 in early trading while Novavax's stock slid 7% to $6.50. Shares of Vaxcyte sank 55% to $31.60 and shares of Sarepta Therapeutics slipped 7% to $65.71. Shares of Pfizer retreated 1.5% to $24.83.

The Wall Street Journal reported Friday that Dr. Peter Marks, who played a critical role in the first Trump administration's Operation Warp Speed to develop Covid-19 vaccines, stepped down after an HHS official gave him the choice to resign or be fired, according to people familiar with the matter.

"It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies," Marks wrote in a resignation letter, referring to Kennedy.

The resignation takes effect on April 5.

 

Write to Dean Seal at dean.seal@wsj.com

 

(END) Dow Jones Newswires

March 31, 2025 10:04 ET (14:04 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10